机译:发现有效和选择性FLT3抑制剂(Z)-N-(5 - ((5-氟-2-氧代吲哚-3- ylidene)甲基)-4-甲基-1H-吡咯-3-Y1)-3-( Pyrrolidin-1-yl)丙酰胺,具有改善的药物状性质和FLT3-ITD阳性急性髓性白血病的优异功效
Nanjing Univ Chinese Med Sch Pharm Jiangsu Key Lab Funct Subst Chinese Med Nanjing 210023 Peoples R China;
Nanjing Univ Chinese Med Sch Pharm Jiangsu Key Lab Funct Subst Chinese Med Nanjing 210023 Peoples R China;
Nanjing Univ Chinese Med Sch Pharm Jiangsu Key Lab Funct Subst Chinese Med Nanjing 210023 Peoples R China;
Nanjing Univ Chinese Med Sch Pharm Jiangsu Key Lab Funct Subst Chinese Med Nanjing 210023 Peoples R China;
ShanghaiTech Univ Shanghai Inst Adv Immunochem Studies Shanghai 201210 Peoples R China;
Nanjing Univ Chinese Med Sch Pharm Jiangsu Key Lab Funct Subst Chinese Med Nanjing 210023 Peoples R China;
Nanjing Univ Chinese Med Sch Pharm Jiangsu Key Lab Funct Subst Chinese Med Nanjing 210023 Peoples R China;
Nanjing Univ Chinese Med Sch Pharm Jiangsu Key Lab Funct Subst Chinese Med Nanjing 210023 Peoples R China;
Nanjing Univ Chinese Med Sch Pharm Jiangsu Key Lab Funct Subst Chinese Med Nanjing 210023 Peoples R China;
Nanjing Univ Chinese Med Sch Pharm Jiangsu Key Lab Funct Subst Chinese Med Nanjing 210023 Peoples R China;
机译:发现新型N-(5-(叔丁基)异恶唑-3-基)-N'-苯基脲类似物作为有效的FLT3抑制剂,并评估其在体内和体外对急性髓细胞性白血病的活性
机译:((S)-5-(甲氧基甲基)-7-(1-甲基-1 H-吲哚-2-基)-2-(三氟甲基)-4,7-二氢吡唑并[1,5-a]嘧啶-的发现6-基)((S)-2-(3-甲基异恶唑-5-基)吡咯烷-1-基)甲酮作为有效的选择性I_(Kur)抑制剂
机译:新的有效和选择性FLT3抑制剂1- {5- [7-(3-吗啉代丙氧基)喹唑啉-4-基硫基]-[1,3,4]噻二唑-2-基} -3-p-甲苯基脲的发现及其体内外抗急性髓性白血病(AML)活性
机译:新型双杂项作为脲酶的有效抑制剂和少细胞毒性剂:3 - ({5 - ((2-氨基-13-噻唑-4-基)甲基)-134-恶二唑-2-基}磺酰基)-N-(UN /取代 - 苯基)丙烷酰胺
机译:发现有效和选择性FLT3抑制剂(Z)N(5 - ((5-氟-2-氧代吲哚键-3- ylidene)甲基)-4-甲基1HPyrrol-3-Y1)-3-(Pyrrolidin-1-Y1)丙酰胺,具有改善的药物状性质和FLT3-ITD阳性急性髓性白血病的优异功效